Hospital‐Onset Clostridium difficile Infection Among Solid Organ Transplant Recipients. Issue 11 (November 2015)

• Record Type: Journal Article
• Authors: Donnelly, J. P.; Wang, H. E.; Locke, J. E.; Mannon, R. B.; Safford, M. M.; Baddley, J. W.
• Is Part Of: American journal of transplantation. Volume 15:Issue 11(2015:Nov.)
• Page Start: 2970
• Page End: 2977
• Publication Date: 2015-11
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ajt.13491
• Languages: English
• ISSNs: 1600-6135

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ajt13491-sec-0001" sec-type="section"> <p> <italic>Clostridium difficile</italic> infection (CDI) is a considerable health issue in the United States and represents the most common healthcare‐associated infection. Solid organ transplant recipients are at increased risk of CDI, which can affect both graft and patient survival. However, little is known about the impact of CDI on health services utilization posttransplantation. We examined hospital‐onset CDI from 2012 to 2014 among transplant recipients in the University HealthSystem Consortium, which includes academic medical center–affiliated hospitals in the United States. Infection was five times more common among transplant recipients than among general medicine inpatients (209 vs 40 per 10 000 discharges), and factors associated with CDI among transplant recipients included transplant type, risk of mortality, comorbidities, and inpatient complications. Institutional risk‐standardized CDI varied more than 3‐fold across high‐volume hospitals (infection ratio 0.54–1.82, median 1.04, interquartile range 0.78–1.28). CDI was associated with increased 30‐day readmission, transplant organ complications, cytomegalovirus infection, inpatient costs, and lengths of stay. Total observed inpatient days and direct costs for those with CDI were substantially higher than risk‐standardized expected values (40 094 vs 22 843 days, costs $198 728 368 vs $154 020 528). Further efforts to detect, prevent, and manage CDI among solid organ transplant recipients are warranted.</p> </sec> </abstract>